Michael Bretthauer is Professor of Medicine at the University of Oslo at the Clinical Effectiveness Research Group, and gastroenterologist at Oslo University Hospital. He is also an Associate Editor of Annals of Internal Medicine and chair of the Clinical Research Center, Department of Transplantation Medicine at Oslo University Hospital.
Honorary Award
Michael Bretthauer’s main clinical activities are in gastrointestinal endoscopy, especially in colonoscopy and colorectal cancer and polyps. He receives the prize on the basis of his long-time contribution of clinical evidence to the field. His main research interests include clinical trials and clinical epidemiology in gastroenterology. He is a lead investigator for several large-scale international clinical trials in colorectal cancer screening and surveillance, such as the Nordic-European Initiative on Colorectal Cancer, the European Polyp Surveillance trials, and the EU-OperA project including the ACCEPT trial. Michael Bretthauer has published more than 300 scientific articles and his current H-index for citation is 52.
Attractive and Active Research Group
Together with his wife Mette Kalager, an internationally recognized expert in medical decision making and clinical epidemiology, Michael Bretthauer has since 2012 built up an internationally competitive clinical research environment in Oslo, the Clinical Effectiveness Group. The group has today around 35 active members of academic faculty based in Europe and USA, PhD and post doc level scientists, clinicians, study nurses and support staff. The group and its partners are running clinical trials and epidemiology studies in gastroenterology across Scandinavia and Europe with altogether more than 400,000 enrolled patients.
Read more about UEG and the prize at UEG.eu.